pd 153035 has been researched along with Multiple Myeloma in 1 studies
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, XY | 1 |
| Huang, JA | 1 |
| Xie, W | 1 |
| Jiang, LY | 1 |
| Wang, YD | 1 |
1 other study available for pd 153035 and Multiple Myeloma
| Article | Year |
|---|---|
[Role of PD153035 in the induction of apoptosis of XG-1 myeloma cell line].
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; DNA-Binding Proteins; ErbB Recept | 2004 |